UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2011

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

APPLE INC.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the

registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act).

Yes No

932,370,000 shares of common stock issued and outstanding as of January 13,

2012

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except share amounts which are reflected in thousands and per share amounts)

September 30,

September 30,

Three Months Ended

December 31,

2011

December 25,

2010

Net sales

46,333

26,741

Cost of sales

25,630

16,443

Gross margin

20,703

10,298

Operating expenses:

Research and development

758

575

Selling, general and administrative

2,605

1,896

Total operating expenses

3,363

2,471

Operating income

17,340

7,827

Other income and expense

137

136

Income before provision for income taxes

17,477

7,963

Provision for income taxes

4,413

1,959

Net income

13,064

6,004

Earnings per common share:

Basic

14.03

6.53

Diluted

13.87

6.43

Shares used in computing earnings per share:

Basic

931,041

919,294

Diluted

941,572

933,154

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except number of shares which are reflected in thousands)

September 30,

September 30,

December 31,

2011

September 24,

2011

ASSETS:

Current assets:

Cash and cash equivalents

10,310

9,815

Short-term marketable securities

19,846

16,137

Accounts receivable, less allowances of $78 and $53, respectively

8,930

5,369

Inventories

1,236

776

Deferred tax assets

1,937

2,014

Vendor non-trade receivables

7,554

6,348

Other current assets

4,958

4,529

Total current assets

54,771

44,988

Long-term marketable securities

67,445

55,618

Property, plant and equipment, net

7,816

7,777

Goodwill

896

896

Acquired intangible assets, net

3,472

3,536

Other assets

4,281

3,556

Total assets

138,681

116,371

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

18,221

14,632

Accrued expenses

11,500

9,247

Deferred revenue

4,886

4,091

Total current liabilities

34,607

27,970

Deferred revenue non-current

2,187

1,686

Other non-current liabilities

11,833

10,100

Total liabilities

48,627

39,756

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000 shares authorized; 932,214 and 929,277 shares issued and outstanding,

respectively

13,961

13,331

Retained earnings

75,709

62,841

Accumulated other comprehensive income

384

443

Total shareholders equity

90,054

76,615

Total liabilities and shareholders equity

138,681

116,371

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

September 30,

September 30,

Three Months Ended

December 31,

2011

December 25,

2010

Cash and cash equivalents, beginning of the period

9,815

11,261

Operating activities:

Net income

13,064

6,004

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation, amortization and accretion

721

356

Share-based compensation expense

420

299

Deferred income tax expense

1,456

823

Changes in operating assets and liabilities:

Accounts receivable, net

(3,561

(517

Inventories

(460

166

Vendor non-trade receivables

(1,206

(433

Other current and non-current assets

(962

(558

Accounts payable

4,314

2,346

Deferred revenue

1,296

634

Other current and non-current liabilities

2,472

653

Cash generated by operating activities

17,554

9,773

Investing activities:

Purchases of marketable securities

(40,175

(19,575

Proceeds from maturities of marketable securities

3,038

3,279

Proceeds from sales of marketable securities

21,472

6,853

Payments for acquisition of property, plant and equipment

(1,321

(1,214

Payments for acquisition of intangible assets

(108

(49

Other

(34

(23

Cash used in investing activities

(17,128

(10,729

Financing activities:

Proceeds from issuance of common stock

91

208

Excess tax benefits from equity awards

333

454

Taxes paid related to net share settlement of equity awards

(355

(233

Cash generated by financing activities

69

429

Increase/(decrease) in cash and cash equivalents

495

(527

Cash and cash equivalents, end of the period

10,310

10,734

Supplemental cash flow disclosure:

Cash paid for income taxes, net

1,474

826

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,

manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and

applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the

Company sells a variety of third-party iPhone, iPad, Macintosh ( Mac ), and iPod compatible products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its

online and retail stores. The Company sells to consumers, small and mid-sized businesses, education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed

consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial

statements and accompanying notes. Actual results could differ materially from those estimates. Prior period costs associated with the Company s high-profile retail stores have been reclassified to conform to the current period s

presentation. Refer to Note 7, Segment Information and Geographic Data, of this Form 10-Q.

These condensed

consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 24, 2011, included in its Annual

Report on Form 10-K (the 2011 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2012 will include 53-weeks and ends on September 29,

2012. An additional week has been included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to particular years or quarters refer to the Company s

fiscal years ended in September and the associated quarters of those fiscal years.

Earnings Per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares

of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to

include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the

employee stock purchase plan and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method. Under the

treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per common share for

the three months ended December 31, 2011 and December 25, 2010 (in thousands, except net income in millions and per share amounts):

September 30,

September 30,

Three Months Ended

December 31,

2011

December 25,

2010

Numerator:

Net income

13,064

6,004

Denominator:

Weighted-average shares outstanding

931,041

919,294

Effect of dilutive securities

10,531

13,860

Weighted-average diluted shares

941,572

933,154

Basic earnings per common share

14.03

6.53

Diluted earnings per common share

13.87

6.43

The number of potentially dilutive securities excluded from the computation of diluted earnings per

common share because their effect would have been antidilutive was not significant for the three months ended December 31, 2011 and December 25, 2010.

Fair Value Measurements

Fair value is the price that would be received

from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value

into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 Quoted prices in active markets for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets,

or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Inputs that are generally unobservable and typically reflect management s estimate of assumptions that market participants would use in pricing the asset or liability.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables summarize the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment

category recorded as cash and cash equivalents or short-term or long-term marketable securities as of December 31, 2011 and September 24, 2011 (in millions):

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

December 31, 2011

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

3,956

3,956

3,956

Level 1:

Money market funds

3,495

3,495

3,495

Mutual funds

1,238

(35

1,203

1,203

Subtotal

4,733

(35

4,698

3,495

1,203

Level 2:

U.S. Treasury securities

14,685

27

(3

14,709

2,789

11,920

U.S. agency securities

20,000

18

(11

20,007

363

4,279

15,365

Non-U.S. government securities

5,251

35

(5

5,281

127

1,642

3,512

Certificates of deposit and time deposits

3,837

3,838

1,462

629

1,747

Commercial paper

1,518

1,518

863

655

Corporate securities

38,914

149

(147

38,916

44

8,127

30,745

Municipal securities

4,078

53

(1

4,130

522

3,608

Asset-backed securities

549

(1

548

548

Subtotal

88,832

283

(168

88,947

2,859

18,643

67,445

Total

97,521

283

(203

97,601

10,310

19,846

67,445

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 24, 2011

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

2,903

2,903

2,903

Level 1:

Money market funds

1,911

1,911

1,911

Mutual funds

1,227

(34

1,193

1,193

Subtotal

3,138

(34

3,104

1,911

1,193

Level 2:

U.S. Treasury securities

10,717

39

(3

10,753

1,250

2,149

7,354

U.S. agency securities

13,467

24

(3

13,488

225

1,818

11,445

Non-U.S. government securities

5,559

11

(2

5,568

551

1,548

3,469

Certificates of deposit and time deposits

4,175

(2

4,175

728

977

2,470

Commercial paper

2,853

2,853

2,237

616

Corporate securities

35,241

132

(114

35,259

10

7,241

28,008

Municipal securities

3,411

56

3,467

595

2,872

Subtotal

75,423

264

(124

75,563

5,001

14,944

55,618

Total

81,464

264

(158

81,570

9,815

16,137

55,618

The net unrealized gains as of December 31, 2011 and September 24, 2011 are related primarily

to long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The

Company recognized no significant net realized gains or losses during the three months ended December 31, 2011 and December 25, 2010 related to such sales. The maturities of the Company s long-term marketable securities generally

range from one to five years.

As of December 31, 2011 and September 24, 2011, gross unrealized losses related to

individual securities that had been in a continuous loss position for 12 months or longer were not significant.

The Company

considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one

issuer. The Company s investment policy requires investments to generally be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the

investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and

any changes thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. During the three months ended December 31, 2011

and December 25, 2010, the Company did not recognize any significant impairment charges. As of December 31, 2011, the Company does not consider any of its investments to be other-than-temporarily impaired.

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the

foreign exchange risk on expected future cash flows on certain forecasted revenue and cost of sales, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain

of the Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies

may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases

generally up to six months.

To help protect the net investment in a foreign operation from adverse changes in foreign

currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.

The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and

losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not

limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency

exchange rates.

The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The

Company s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income

( AOCI ) until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. The ineffective portions of cash flow

hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item the derivative relates to.

The Company had a net deferred gain associated with cash flow hedges of approximately $223 million and $290 million, net of

taxes, recorded in AOCI as of December 31, 2011 and September 24, 2011, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as

the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all of the

Company s hedged transactions as of December 31, 2011 are expected to occur within six months.

Derivative

instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and

losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are

re-designated as hedges of other transactions. The Company did not recognize any material net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 31, 2011 and

December 25, 2010.

The Company s unrealized net gains and losses on net investment hedges, included in the

cumulative translation adjustment account of AOCI, were not significant as of December 31, 2011 and September 24, 2011, respectively. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are

recorded in other income and expense.

During the three months ended December 31, 2011 and December 25, 2010, the

gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant. These amounts represent the net gain or loss on the derivative contracts and do not include

changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.

The following table shows the notional principal amounts of the Company s outstanding

derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 31, 2011 and September 24, 2011 (in millions):

September 30,

September 30,

September 30,

September 30,

December 31, 2011

September 24, 2011

Notional

Principal

Credit Risk

Amounts

Notional

Principal

Credit Risk

Amounts

Instruments qualifying as accounting hedges:

Foreign exchange contracts

12,323

415

13,705

537

Instruments other than accounting hedges:

Foreign exchange contracts

15,988

85

9,891

56

The notional principal amounts for outstanding derivative instruments provide one measure of the

transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that

are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be

further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal

and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately

realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with

the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from

contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. The Company received cash collateral related to the derivative instruments under its collateral security

arrangements of $526 million and $288 million as of December 31, 2011 and September 24, 2011, respectively. These amounts are classified as accrued expenses in the Condensed Consolidated Balance Sheets. The Company did not have any

derivative instruments with credit risk-related contingent features that would require it to post additional collateral as of December 31, 2011 or September 24, 2011.

The following tables show the Company s derivative instruments measured at gross fair value as reflected in the Condensed

Consolidated Balance Sheets as of December 31, 2011 and September 24, 2011 (in millions):

September 30,

September 30,

September 30,

December 31, 2011

Fair Value

of

Derivatives

Designated

as

Hedge

Instruments

Fair Value

of

Derivatives

Not Designated

as

Hedge

Instruments

Total

Fair Value

Derivative assets (a):

Foreign exchange contracts

358

85

443

Derivative liabilities (b):

Foreign exchange contracts

42

45

87

10

September 30,

September 30,

September 30,

September 24, 2011

Fair Value of

Derivatives

Designated

as Hedge

Instruments

Fair Value of

Derivatives

Not Designated

as Hedge

Instruments

Total

Fair Value

Derivative assets (a):

Foreign exchange contracts

460

56

516

Derivative liabilities (b):

Foreign exchange contracts

72

37

109

(a)

The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed

Consolidated Balance Sheets.

(b)

The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed

Consolidated Balance Sheets.

The following table shows the pre-tax effect of the Company s derivative

instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three months ended December 31, 2011 and December 25, 2010 (in millions):

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

Gains/(Losses) Recognized in

OCI - Effective Portion (c)

Gains/(Losses) Reclassified

from AOCI into Income -

Effective Portion (c)

Gains/(Losses) Recognized

Ineffective

Portion and Amount Excluded from

Effectiveness Testing

December 31,

2011

December 25,

2010

December 31,

2011 (a)

December 25,

2010 (b)

Location

December 31,

2011

December 25,

2010

Cash flow hedges:

Foreign exchange contracts

135

(66

238

(449

Other income

and expense

(69

21

Net investment hedges:

Foreign exchange contracts

(3

Other income

and expense

Total

142

(69

238

(449

(68

21

(a)

Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $187 million and $51 million

were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended December 31, 2011. There were no amounts reclassified from AOCI into net income for the

effective portion of net investment hedges for the three months ended December 31, 2011.

(b)

Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(257) million and $(192)